| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 05/18/2010 | US7718701 Prostaglandin, e.g., 1R,2R,3R,5R)-5-halo-2-[(1E,3S)-3-cycloalkyl-3-hydroxy-1-propenyl]-3-hydroxycyclopentyl]-(5Z)-5-alkenoic acids; treating in particular, symptoms of atopic dermatitis |
| 05/18/2010 | US7718664 Anti-itching agent |
| 05/18/2010 | US7718663 Quinazoline derivatives and medicaments |
| 05/18/2010 | US7718662 Pyrazolo-pyrimidine inhibitors of bruton's tyrosine kinase |
| 05/18/2010 | US7718646 Cyclohexyl(alkyl)propanolamines, preparation method and pharmaceutical compositions containing same |
| 05/18/2010 | US7718623 Immunostimulatory oligonucleotide that induces interferon alpha |
| 05/18/2010 | US7718599 Peptides present in form of acetate, gluconate, glucuronate, lactate, citrate, ascorbate, benzoate or phosphate salts and administration forms also contain one of above acids as free acids; for treating sex hormone-dependent diseases |
| 05/18/2010 | US7718426 Preparation method of a hair dermal papilla cell preparation, composition and method for regenerating hair follicles, and animal having regenerated hair follicles |
| 05/18/2010 | US7718391 Assays for identifying modulators of rhomboid polypeptides |
| 05/18/2010 | US7718376 Identification and isolation of somatic stem cells and uses thereof |
| 05/18/2010 | US7718185 Inhibitors of melanocyte tyrosinase as topical skin lighteners |
| 05/18/2010 | US7718177 Antibodies directed to fragments of connective tissue growth factor (CTGF) polypeptide and methods and uses thereof |
| 05/18/2010 | CA2472475C 17-hydroxy-4-aza-androstan-3-ones as androgen receptor modulators |
| 05/18/2010 | CA2465247C Benzimidazoles and analogues and their use as protein kinases inhibitors |
| 05/18/2010 | CA2422371C Pyrazole compounds useful as protein kinase inhibitors |
| 05/18/2010 | CA2422367C Pyrazole compounds useful as protein kinase inhibitors |
| 05/18/2010 | CA2383357C Use of tosylchloramide(s) for treating diseases of the skin, mucous membranes, organs and tissues |
| 05/18/2010 | CA2368965C Recombinant il-18 antagonists useful in treatment of il-18 mediated disorders |
| 05/18/2010 | CA2302808C 50 human secreted proteins |
| 05/18/2010 | CA2171266C Stable transglutaminase preparations and processes for producing them |
| 05/14/2010 | WO2010053182A1 Kynurenine production inhibitor |
| 05/14/2010 | WO2010052568A1 Method for the preparation of medical devices and devices obtained therefrom |
| 05/14/2010 | WO2010052430A2 Heat sterilised injectable composition of hyaluronic acid or one of the salts thereof, polyols and lidocaine |
| 05/14/2010 | WO2010052329A1 The use of compounds to inhibit 5a-reductase enzyme activity, and pharmaceutical and cosmetic compositions containing them |
| 05/14/2010 | WO2010052328A1 Diene compounds for use in human epidermal cell repair, and pharmaceutical and cosmetic compositions containing them |
| 05/14/2010 | WO2010052312A2 Drug or dermatological composition containing an avocado peptide extract for treating and preventing pruritus |
| 05/14/2010 | WO2010052027A1 Combinational therapy comprising dhodh inhibitor and methotrexate for treating autoimmune disease |
| 05/14/2010 | WO2010051852A1 Compositions containing interleukin-1 and peptides |
| 05/14/2010 | WO2010051641A1 Oxidatitive photoactivated skin rejeuvenation composition comprising hyaluronic acid, glucosamine, or allantoin |
| 05/14/2010 | WO2010051636A1 Combination of an oxidant and a photoactivator for the healing of wounds |
| 05/14/2010 | WO2010033292A9 Method for medical treatment utilizing l-glutathione |
| 05/14/2010 | WO2010027603A3 Compositions comprising solid particles encapsulated in a cross-linked silicone matrix, and methods of making the same |
| 05/14/2010 | WO2010027189A9 A new use for homoisoflavanone or a salt thereof |
| 05/14/2010 | WO2010025438A9 Methods of treatment using single doses of oritavancin |
| 05/14/2010 | WO2010009405A3 Targeted nitroxide agents |
| 05/14/2010 | WO2010006184A3 Small-molecule inhibitors of hif and angiogenesis |
| 05/14/2010 | CA2743216A1 The use of compounds to inhibit 5a-reductase enzyme activity, and pharmaceutical and cosmetic compositions containing them |
| 05/14/2010 | CA2743212A1 Diene compounds for use in human epidermal cell repair, and pharmaceutical and cosmetic compositions containing them |
| 05/14/2010 | CA2742943A1 Oxidatitive photoactivated skin rejeuvenation composition comprising hyaluronic acid, glucosamine, or allantoin |
| 05/14/2010 | CA2742942A1 Combination of an oxidant and a photoactivator for the healing of wounds |
| 05/14/2010 | CA2742910A1 Combinational therapy comprising dhodh inhibitor and methotrexate for treating autoimmune disease |
| 05/14/2010 | CA2742099A1 Heat sterilised injectable composition of hyaluronic acid or one of the salts thereof, polyols and lidocaine |
| 05/13/2010 | US20100122356 Pig model for psoriasis |
| 05/13/2010 | US20100121255 Compound |
| 05/13/2010 | US20100121254 Method and apparatus for skin treatment |
| 05/13/2010 | US20100120912 Esters of capsaicinoids as dietary supplements |
| 05/13/2010 | US20100120909 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof |
| 05/13/2010 | US20100120907 Derivatives of amyris alcohols and eudesmol for treating cold sores and herpes |
| 05/13/2010 | US20100120889 Skin care composition for accelerated production of collagen proteins and method of fabricating the same |
| 05/13/2010 | US20100120883 Novel compounds |
| 05/13/2010 | US20100120865 thiazol-2-yl-urea derivatives such as 3-{3-[4-Methyl-5-(4-pyrazol-1-yl-phenyl)-thiazol-2-yl]-ureido}-N-pyridin-3-yl-propionamide, used in the treatment of diseases ameloriated by inhibition of phosphatidylinositol 3-kinase, particularly inflammatory, allergic or autoimmune conditions |
| 05/13/2010 | US20100120851 Prenyltransferase inhibitors for ocular hypertension control and the treatment of glaucoma |
| 05/13/2010 | US20100120837 Method of treating a mucosal and/or dermal associated condition |
| 05/13/2010 | US20100120836 Method of treating a dermal and/or mucosal associated condition |
| 05/13/2010 | US20100120834 Reduction of imiquimod impurities at four months using refined oleic acid |
| 05/13/2010 | US20100120824 Method of preparing a pharmaceutical cream and minimizing imiquimod impurity formation |
| 05/13/2010 | US20100120815 Stable solid preparation containing 4,5-epoxymorphinan derivative |
| 05/13/2010 | US20100120807 Compounds and compositions as modulators of gpr119 activity |
| 05/13/2010 | US20100120804 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 05/13/2010 | US20100120768 Methods, kits, and compositions for generating new hair follicles and growing hair |
| 05/13/2010 | US20100120766 Substituted Pteridines |
| 05/13/2010 | US20100120731 3-([1,2,4]triazolo [4,3-a]pyridin-7-yl)benzamide derivatives |
| 05/13/2010 | US20100120696 Peptides Having Activities of Epidermal Growth Factor and Its Uses |
| 05/13/2010 | US20100120668 Method of treatment of photodermatoses |
| 05/13/2010 | US20100120070 Precise efficacy assay methods for active agents including chemotherapeutic agents |
| 05/13/2010 | US20100120015 Method of collecting placental stem cells |
| 05/13/2010 | US20100119632 Cleome spinosa extract used in pharmaceutical preparations and cosmetic compositions |
| 05/13/2010 | US20100119616 Highly stable electrolytic water with reduced nmr half line width |
| 05/13/2010 | US20100119574 Recombinant Gelatins |
| 05/13/2010 | US20100119555 Methods and Compositions for the Treatment and Diagnosis of Cancer |
| 05/13/2010 | US20100119521 Compositions and methods for treating cancer by modulating her-2 and egf receptors |
| 05/13/2010 | US20100119495 Human skin equivalents expressing exogenous polypeptides |
| 05/12/2010 | EP2184296A1 Fibroblast growth factor (fgf23) and methods for use |
| 05/12/2010 | EP2184281A1 Phenyl-thiophene type vitamin D receptor modulators |
| 05/12/2010 | EP2184085A1 Treatment of diseases |
| 05/12/2010 | EP2182964A2 Use of an active principle from flax for use in a composition for activating cytochrome c |
| 05/12/2010 | EP1828113B1 2-methylene-19,26,27-trinor-(20s)-1-alpha-hydroxyvitamin d3 and its uses |
| 05/12/2010 | CN1981815B Hand and foot antibacterial detergent and its production |
| 05/12/2010 | CN1970014B Chinese medicinal powder or lotion for treating dermatomycosis and method for preparing same |
| 05/12/2010 | CN1965958B Remedy for treating burn and scald |
| 05/12/2010 | CN1951430B Compound Chinese medicine for treating psoriasis and lupus erythematosus |
| 05/12/2010 | CN1943600B Medicinal composition containing American cockroach and its ethanol extract and new use |
| 05/12/2010 | CN1923244B Medicinal composition for treating dermatosis, preparation process and use thereof |
| 05/12/2010 | CN1907328B Kuh-seng gel formulation and its preparing process |
| 05/12/2010 | CN1903342B Identification and assaying method for extractive of flowers and leaves of pseudo-ginseng |
| 05/12/2010 | CN1899457B Detecting method and measuring standard for safflower content in skin itch treating preparation |
| 05/12/2010 | CN1899355B Ointment for clearing pestilent factor and toxic matter |
| 05/12/2010 | CN1895451B Medicinal composition for treating hives and eczema and its preparation |
| 05/12/2010 | CN1895445B Compound Chinese-medicinal preparation for treating clavus |
| 05/12/2010 | CN1887324B Chinese medicine composition for treating liver and kidney defect, and its preparation process and analysis method |
| 05/12/2010 | CN1887308B Medicine for treating tinea manuum and tinea pedis and preparation of medicine cream |
| 05/12/2010 | CN1853609B Skin-care effectiveness applied by acid fiber mother cell growth factor (FGF-1) |
| 05/12/2010 | CN1819824B Use of an antioxidant in a dermatological and/or cosmetic composition |
| 05/12/2010 | CN1803166B Capsule for blackening and generating hair, and its preparation process |
| 05/12/2010 | CN1695662B Medicine for treating psoriasis |
| 05/12/2010 | CN1671856B Novel physiologically active substances |
| 05/12/2010 | CN1646558B Histone deacetylase inhibitors and process for producing the same |
| 05/12/2010 | CN1636994B Process of preparing alkali metal salys of hydrophobic sulfonamides and alkali metal salt produced thereby |
| 05/12/2010 | CN101705157A Aromatic candle with skin care effect and preparation method thereof |
| 05/12/2010 | CN101704826A Chinese medicinal lilac daphne flower bud diterpene ortho-ester compounds |